OvaScience
Company

Last deal

$53.8M

Amount

Post-IPO Equity

Stage

01.06.2016

Date

7

all rounds

$317.8M

Total amount

General

About Company
OvaScience is a company focused on developing new treatment options for infertility.

Industry

Sector :

Subsector :

founded date

01.01.2011

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

Leveraging their proprietary technology platform, OvaScience is working on treatments like OvaPrime, which aims to restore a woman's egg production, and OvaTure, which eliminates the need for hormone stimulation. They have also developed AUGMENT, a treatment available in Japan that improves fertilization and pregnancy rates. With a team of experts and partnerships with renowned institutions, OvaScience is dedicated to addressing the challenges faced by women and families struggling with infertility.
Contacts

Phone number

Social url